Merck inks deal with Unnatural Products; CG Oncology’s upsized IPO; Locus gets $24M from BARDA
Plus, news about Outlook Therapeutics and Adicet Bio:
Merck and Unnatural Products collaborate: Per the deal, Merck will make an undisclosed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.